Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from...
The hacker behind the Verus bridge exploit returned 75% of the stolen funds as part of a...
Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The...
Indian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank...
The organised gold jewellery retail sector is set for a steep 13–15% volume decline to a decade...
Indian real estate is seeing a major shift. Domestic investors are now leading capital flows, moving away...
Market expert Vikas Khemani anticipates a consolidation phase for Indian equities rather than a sharp breakout, citing...
Bitcoin rallied for 90 days after its dip below $60,000, breaking the record for the longest uptrend...
Indian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial’s Ashish...
Despite the Nifty Microcap 250 index remaining largely flat over the past year, several microcap stocks delivered...